<i>PPARG</i>, <i>TMEM163</i>, <i>UBE2E2</i>, and <i>WFS1</i> Gene Polymorphisms Are Not Significant Risk Factors for Gestational Diabetes in the Polish Population

Gestational diabetes mellitus (GDM) is a common disorder that occurs in pregnant women, leading to many maternal and neonatal complications. The pathogenesis of GDM is complex and includes risk factors, such as: age, obesity, and family history of diabetes. Studies have shown that genetic factors al...

Full description

Bibliographic Details
Main Authors: Przemysław Ustianowski, Damian Malinowski, Krzysztof Safranow, Violetta Dziedziejko, Maciej Tarnowski, Andrzej Pawlik
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Journal of Personalized Medicine
Subjects:
Online Access:https://www.mdpi.com/2075-4426/12/2/243
_version_ 1797478825445031936
author Przemysław Ustianowski
Damian Malinowski
Krzysztof Safranow
Violetta Dziedziejko
Maciej Tarnowski
Andrzej Pawlik
author_facet Przemysław Ustianowski
Damian Malinowski
Krzysztof Safranow
Violetta Dziedziejko
Maciej Tarnowski
Andrzej Pawlik
author_sort Przemysław Ustianowski
collection DOAJ
description Gestational diabetes mellitus (GDM) is a common disorder that occurs in pregnant women, leading to many maternal and neonatal complications. The pathogenesis of GDM is complex and includes risk factors, such as: age, obesity, and family history of diabetes. Studies have shown that genetic factors also play a role in the pathogenesis of GDM. The present study investigated whether polymorphisms in the <i>PPARG</i> (rs1801282), <i>TMEM163</i> (rs6723108 and rs998451), <i>UBE2E2</i> (rs6780569), and <i>WFS1</i> (rs4689388) genes are risk factors for the development of GDM and whether they affect selected clinical parameters in women with GDM. This study included 204 pregnant women with GDM and 207 pregnant women with normal glucose tolerance (NGT). The diagnosis of GDM was based on a 75 g oral glucose tolerance test (OGTT) at 24–28 weeks gestation, according to the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria. There were no statistically significant differences in the distribution of polymorphisms studied between women with GDM and pregnant women with normal carbohydrate tolerance, which suggests that these polymorphisms are not risk factors for GDM. We also examined the associations between studied gene polymorphisms and clinical parameters: fasting glucose, daily insulin requirement, body mass before pregnancy, body mass at birth, body mass increase during pregnancy, BMI before pregnancy, BMI at birth, BMI increase during pregnancy, new-born body mass, and APGAR score in women with GDM. We observed lower BMI values before pregnancy and at birth in women with <i>PPARG</i> rs17036160 TT genotype. The results of this study suggest that the <i>PPARG</i> (rs1801282), <i>TMEM163</i> (rs6723108 and rs998451), <i>UBE2E2</i> (rs6780569), and <i>WFS1</i> (rs4689388) gene polymorphisms are not significant risk factors for GDM development in the Polish population and do not affect the clinical parameters in women with GDM; only rs1801282 of the <i>PPARG</i> gene may influence BMI values in women with GDM.
first_indexed 2024-03-09T21:37:06Z
format Article
id doaj.art-364a6e772dea47be87e65cecc30d9ba3
institution Directory Open Access Journal
issn 2075-4426
language English
last_indexed 2024-03-09T21:37:06Z
publishDate 2022-02-01
publisher MDPI AG
record_format Article
series Journal of Personalized Medicine
spelling doaj.art-364a6e772dea47be87e65cecc30d9ba32023-11-23T20:40:25ZengMDPI AGJournal of Personalized Medicine2075-44262022-02-0112224310.3390/jpm12020243<i>PPARG</i>, <i>TMEM163</i>, <i>UBE2E2</i>, and <i>WFS1</i> Gene Polymorphisms Are Not Significant Risk Factors for Gestational Diabetes in the Polish PopulationPrzemysław Ustianowski0Damian Malinowski1Krzysztof Safranow2Violetta Dziedziejko3Maciej Tarnowski4Andrzej Pawlik5Department of Obstetrics and Gynecology, Pomeranian Medical University, 70-111 Szczecin, PolandDepartment of Experimental and Clinical Pharmacology, Pomeranian Medical University, 70-111 Szczecin, PolandDepartment of Biochemistry and Medical Chemistry, Pomeranian Medical University, 70-111 Szczecin, PolandDepartment of Biochemistry and Medical Chemistry, Pomeranian Medical University, 70-111 Szczecin, PolandDepartment of Physiology, Pomeranian Medical University, 70-111 Szczecin, PolandDepartment of Physiology, Pomeranian Medical University, 70-111 Szczecin, PolandGestational diabetes mellitus (GDM) is a common disorder that occurs in pregnant women, leading to many maternal and neonatal complications. The pathogenesis of GDM is complex and includes risk factors, such as: age, obesity, and family history of diabetes. Studies have shown that genetic factors also play a role in the pathogenesis of GDM. The present study investigated whether polymorphisms in the <i>PPARG</i> (rs1801282), <i>TMEM163</i> (rs6723108 and rs998451), <i>UBE2E2</i> (rs6780569), and <i>WFS1</i> (rs4689388) genes are risk factors for the development of GDM and whether they affect selected clinical parameters in women with GDM. This study included 204 pregnant women with GDM and 207 pregnant women with normal glucose tolerance (NGT). The diagnosis of GDM was based on a 75 g oral glucose tolerance test (OGTT) at 24–28 weeks gestation, according to the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria. There were no statistically significant differences in the distribution of polymorphisms studied between women with GDM and pregnant women with normal carbohydrate tolerance, which suggests that these polymorphisms are not risk factors for GDM. We also examined the associations between studied gene polymorphisms and clinical parameters: fasting glucose, daily insulin requirement, body mass before pregnancy, body mass at birth, body mass increase during pregnancy, BMI before pregnancy, BMI at birth, BMI increase during pregnancy, new-born body mass, and APGAR score in women with GDM. We observed lower BMI values before pregnancy and at birth in women with <i>PPARG</i> rs17036160 TT genotype. The results of this study suggest that the <i>PPARG</i> (rs1801282), <i>TMEM163</i> (rs6723108 and rs998451), <i>UBE2E2</i> (rs6780569), and <i>WFS1</i> (rs4689388) gene polymorphisms are not significant risk factors for GDM development in the Polish population and do not affect the clinical parameters in women with GDM; only rs1801282 of the <i>PPARG</i> gene may influence BMI values in women with GDM.https://www.mdpi.com/2075-4426/12/2/243gestational diabetespolymorphismgenetics
spellingShingle Przemysław Ustianowski
Damian Malinowski
Krzysztof Safranow
Violetta Dziedziejko
Maciej Tarnowski
Andrzej Pawlik
<i>PPARG</i>, <i>TMEM163</i>, <i>UBE2E2</i>, and <i>WFS1</i> Gene Polymorphisms Are Not Significant Risk Factors for Gestational Diabetes in the Polish Population
Journal of Personalized Medicine
gestational diabetes
polymorphism
genetics
title <i>PPARG</i>, <i>TMEM163</i>, <i>UBE2E2</i>, and <i>WFS1</i> Gene Polymorphisms Are Not Significant Risk Factors for Gestational Diabetes in the Polish Population
title_full <i>PPARG</i>, <i>TMEM163</i>, <i>UBE2E2</i>, and <i>WFS1</i> Gene Polymorphisms Are Not Significant Risk Factors for Gestational Diabetes in the Polish Population
title_fullStr <i>PPARG</i>, <i>TMEM163</i>, <i>UBE2E2</i>, and <i>WFS1</i> Gene Polymorphisms Are Not Significant Risk Factors for Gestational Diabetes in the Polish Population
title_full_unstemmed <i>PPARG</i>, <i>TMEM163</i>, <i>UBE2E2</i>, and <i>WFS1</i> Gene Polymorphisms Are Not Significant Risk Factors for Gestational Diabetes in the Polish Population
title_short <i>PPARG</i>, <i>TMEM163</i>, <i>UBE2E2</i>, and <i>WFS1</i> Gene Polymorphisms Are Not Significant Risk Factors for Gestational Diabetes in the Polish Population
title_sort i pparg i i tmem163 i i ube2e2 i and i wfs1 i gene polymorphisms are not significant risk factors for gestational diabetes in the polish population
topic gestational diabetes
polymorphism
genetics
url https://www.mdpi.com/2075-4426/12/2/243
work_keys_str_mv AT przemysławustianowski ippargiitmem163iiube2e2iandiwfs1igenepolymorphismsarenotsignificantriskfactorsforgestationaldiabetesinthepolishpopulation
AT damianmalinowski ippargiitmem163iiube2e2iandiwfs1igenepolymorphismsarenotsignificantriskfactorsforgestationaldiabetesinthepolishpopulation
AT krzysztofsafranow ippargiitmem163iiube2e2iandiwfs1igenepolymorphismsarenotsignificantriskfactorsforgestationaldiabetesinthepolishpopulation
AT violettadziedziejko ippargiitmem163iiube2e2iandiwfs1igenepolymorphismsarenotsignificantriskfactorsforgestationaldiabetesinthepolishpopulation
AT maciejtarnowski ippargiitmem163iiube2e2iandiwfs1igenepolymorphismsarenotsignificantriskfactorsforgestationaldiabetesinthepolishpopulation
AT andrzejpawlik ippargiitmem163iiube2e2iandiwfs1igenepolymorphismsarenotsignificantriskfactorsforgestationaldiabetesinthepolishpopulation